Displaced Greater Tuberosity Fractures With Rotator Cuff Injury
Starting soon · Not applicable
Conditions studied: Greater Tuberosity Fracture, Rotator Cuff
In brief
Study Type: Prospective, three-arm parallel randomized controlled trial (RCT) Study Objective: To compare the 12-month/5 years/10years functional outcomes, morphological healing, cost-effectiveness, and complication rates of three treatment strategies for displaced greater tuberosity (GT) fractures with rotator cuff injury, and to optimize the individualized treatment strategy for GT fractures. Study Setting: multicenter clinical trial, conducted in the Department of Orthopedics. Study Period: April 2026 -April 2036.
Key facts
- Study ID
- NCT07503691
- Run by
- Guo Jialiang
- People needed
- 180
- Starts
- 2026-04-01
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2026-03-31
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- • Age 18-76 years, male or female;
- Diagnosed with displaced GT fracture (displacement distance ≥1mm) combined with rotator cuff injury (partial tear or full-thickness tear) by computed tomography (CT) or magnetic resonance imaging (MRI);
- Time from fracture to admission ≤72 hours (acute phase);
- No severe heart, liver, kidney or other underlying diseases, and able to cooperate with 12-month complete follow-up;
- Signed informed consent and voluntarily participated in the trial.
You may not qualify if…
- • Pathological fracture or old fracture (>3 weeks);
- Complicated with shoulder dislocation or other proximal humeral fractures;
- Previous shoulder surgery history, rheumatoid arthritis, or severe osteoporosis;
- Mental illness, cognitive impairment, unable to complete functional scoring;
- Poor follow-up compliance, expected to be unable to complete 12-month follow-up.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.